Ashleigh O’Connell
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Pharmacy top 5%
Papers in
-
- Hedgehog Signaling Pathway Studies 14
- Chromatin Remodeling and Cancer 4
- Protein Degradation and Inhibitors 2
- Hematology 10
- Acute Myeloid Leukemia Research 8
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Jörge E. Cortes (16 shared papers)Geoffrey Chan (16 shared papers)Weidong Wendy (11 shared papers)M. Naveed Shaik (5 shared papers)Mirjana Zeremski (13 shared papers)Daniel A. Pollyea (5 shared papers)Tadeusz Robak (5 shared papers)Alexander Laird (3 shared papers)
- Journals
- Blood (4 papers)Journal of Clinical Oncology (4 papers)HemaSphere (2 papers)Clinical Cancer Research (1 paper)Journal of Hematology & Oncology (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Ashleigh O’Connell
19 papers receiving 801 citations
Ashleigh O’Connell's Hit Papers
Peers
Comparison fields: 5 of 39
- Hematology 502
- Pharmacy 43
- Genetics 90
- Molecular Biology 543
- Pathology and Forensic Medicine 109
Countries citing papers authored by Ashleigh O’Connell
This map shows the geographic impact of Ashleigh O’Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashleigh O’Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashleigh O’Connell more than expected).
Fields of papers citing papers by Ashleigh O’Connell
This network shows the impact of papers produced by Ashleigh O’Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashleigh O’Connell. The network helps show where Ashleigh O’Connell may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashleigh O’Connell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome Hit paper breakdown → | 2018 | 371 |
| 2 | 2015 | 98 | |
| 3 | 2018 | 97 | |
| 4 | 2018 | 88 | |
| 5 | 2021 | 40 | |
| 6 | 2016 | 38 | |
| 7 | 2020 | 29 | |
| 8 | 2019 | 11 | |
| 9 | 2022 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2019 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2020 | 1 |
About Ashleigh O’Connell
Ashleigh O’Connell is a scholar working on Molecular Biology, Hematology, Pathology and Forensic Medicine, Genetics and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 819 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (14 papers), Acute Myeloid Leukemia Research (8 papers), Tumors and Oncological Cases (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers), Chromatin Remodeling and Cancer (4 papers), Acute Lymphoblastic Leukemia research (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Hematology (502 citations), Pharmacy (43 citations), Genetics (90 citations), Molecular Biology (543 citations) and Pathology and Forensic Medicine (109 citations). Ashleigh O’Connell has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Jörge E. Cortes, Geoffrey Chan, Weidong Wendy, M. Naveed Shaik, Mirjana Zeremski, Daniel A. Pollyea, Tadeusz Robak, Alexander Laird, Michael Heuser and Walter Fiedler. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Clinical Cancer Research and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.